Table 2.
Changes in the biochemical analysis of blood samples in subjects on the bacteriophage therapy (BPh). * Correlation is statistically significant.
| Parameters | Reference Values | Subjects, Median (Q1; Q3) | p Value | |
|---|---|---|---|---|
| Before BPh | After BPh | |||
| Bilirubin | 5–21 µmol/L | 15.6 (11.4; 18.8) | 12.5 (11.2; 18.5) | 0.058 |
| Total protein | 66–83 g/L | 69.1 (66.3; 71.5) | 71.2 (68.4; 72.6) | 0.038 * |
| Creatinine | 74–110 µmol/L | 82 (74; 103) | 89 (80; 98) | 0.657 |
| Glucose | 4.1–5.9 mmol/L | 5.7 (5.1; 5.9) | 5.6 (5.2; 6.0) | 0.236 |
| Cholesterol | 0–5.2 mmol/L | 5.5 (4.5; 7.1) | 5.9 (4.5; 6.2) | 0.154 |
| Lactate dehydrogenase | 0–247 u/L | 198 (168; 223) | 197 (168; 229) | 0.137 |
| Alanine aminotransferase | 0–50 u/L | 21 (17; 32) | 20 (15; 31) | 0.679 |
| Aspartate aminotransferase | 0–50 u/L | 23 (19; 32) | 24 (19; 29.5) | 0.225 |
| C-reactive protein (CRP) | 0–5 mg/L | 0.6 (0.1; 0.9) | 0.12 (0.1; 0.6) | 0.061 |